When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARCT - Arcturus Therapeutics on go with Phase 1/2 study on COVID-19 vaccine
Arcturus Therapeutics Ltd.
Singapore's Health Sciences Authority has signed off on Phase 1/2 clinical trial evaluating Arcturus Therapeutics Holdings (NASDAQ:ARCT) and Duke-NUs Medical School's mRNA-based COVID-19 vaccine candidate LUNAR-COV19 in up to 108 healthy adult volunteers.
More news on: Arcturus Therapeutics Holdings Inc., Healthcare stocks news,